Stroke survivor experiencing fatigue at home
PEMF UKSTROKE · FATIGUE

rTMS and PEMF for post-stroke fatigue

Affects up to 70% of stroke survivors. Magnetic-stimulation evidence is early. Modifiable contributors come first.

Reviewed 20 May 2026Cited to sourceEditorial, not medical advice

In 40 seconds

Post-stroke fatigue affects up to 70% of stroke survivors and is one of the most under-treated symptoms. Mechanism is poorly understood — likely multifactorial (inflammation, deconditioning, depression, sleep disorders, medication side effects). Magnetic-stimulation evidence is small-pilot only — no phase-3 RCT specifically for post-stroke fatigue. Some signal in studies that measured fatigue as secondary outcome alongside motor or depression endpoints. Consumer PEMF mats have no completed post-stroke fatigue RCT. NICE NG236 pathway is to address modifiable contributors first: screen for depression, sleep disorders (including OSA which is underdiagnosed post-stroke), thyroid function, medication review, vitamin B12, iron, anaemia. Graded exercise has the strongest evidence of any intervention for post-stroke fatigue.

Quick facts

Why post-stroke fatigue is the under-treated symptom

Post-stroke fatigue is one of the symptoms most likely to limit return-to-life after stroke and one of the least well-targeted by specific interventions. The pathophysiology is poorly understood — central inflammation, deconditioning, mood, sleep disruption and medication side effects all contribute. The Fatigue Severity Scale (FSS) and Fatigue Assessment Scale (FAS) are the most-used measures.

Magnetic-stimulation evidence is small. Some rTMS-depression trials in stroke survivors have measured fatigue as a secondary outcome with positive signals; no phase-3 RCT has fatigue as primary endpoint. Consumer PEMF mats have no completed post-stroke fatigue RCT — extrapolation from MS-fatigue PEMF evidence (which is itself modest) is not appropriate.

NICE NG236 pathway is structured: identify and treat modifiable contributors first. Depression is the highest-yield target (SSRI ± psychological therapy). Sleep disorders — particularly obstructive sleep apnoea, which is underdiagnosed post-stroke — are second. Thyroid function, B12, ferritin, full blood count are basic screens worth doing. Polypharmacy review — particularly sedating medications, antihistamines, opioids, anticholinergics — is high-value.

Graded exercise has the strongest evidence of any intervention for post-stroke fatigue (paradoxical-seeming but well-replicated). Stroke physiotherapy services in the UK increasingly include fatigue-focused exercise programmes.

Frequently asked questions

Can rTMS reduce my post-stroke fatigue?

Small pilot evidence only. No phase-3 RCT with fatigue as primary endpoint. UK access via research trial.

Will a PEMF mat help post-stroke fatigue?

No completed RCT supports this. Address modifiable contributors first.

What's the first thing to do for post-stroke fatigue?

Get screened for depression, sleep apnoea, thyroid disease, anaemia and B12. These are common, treatable contributors.

Does exercise really help post-stroke fatigue?

Yes — paradoxically. Graded exercise has the strongest evidence. Stroke physio services increasingly offer fatigue-focused programmes.

Should I be screened for sleep apnoea?

Yes if there are symptoms (snoring, witnessed apnoea, daytime sleepiness). OSA is underdiagnosed post-stroke and worsens both fatigue and stroke outcomes.

Could my medications worsen fatigue?

Possibly. Beta-blockers, sedating antihistamines, opioids, anticholinergics, some antiepileptics all contribute. Polypharmacy review is high-yield.

Is post-stroke fatigue the same as MS fatigue?

Different mechanisms but similar phenomenology. The PEMF MS-fatigue evidence does not directly transfer to post-stroke fatigue.

How long after my stroke will fatigue improve?

Variable. Many survivors notice gradual improvement over 6-12 months. Persistent severe fatigue at 6+ months warrants systematic evaluation.

Editorial standards Independent UK editorial review, not medical advice. Every clinical claim is cited to a primary source. We include negative trials (NICHE 2018) by design and have no commercial relationship with any device manufacturer. Last reviewed: 20 May 2026.
← Stroke (pillar) Arm recovery → Leg recovery → Aphasia → MS fatigue → ME/CFS →

Looking for a PEMF clinic in the UK?

We list every credible PEMF therapy provider in the UK. No UK clinic can legally claim to treat stroke with PEMF or rTMS.